Pfizer price bias bearish after president Biden interview
Technical Analysis Summary Pfizer Inc.: Sell
| Indicator | Value | Signal |
| RSI | Neutral | |
| MACD | Sell | |
| Donchian Channel | Sell | |
| MA(200) | Sell | |
| Fractals | Sell | |
| Parabolic SAR | Sell |
Chart Analysis
The technical analysis of the Pfizer stock price chart on daily timeframe shows #S-PFE,Daily is falling under the 200-day moving average MA(200) which is declining itself. We believe the bearish momentum will continue after the price breaches below the lower boundary of Donchian channel at 43.89. This level can be used as an entry point for placing a pending order to sell. The stop loss can be placed at 46.60. After placing the order, the stop loss is to be moved every day to the next fractal high, following Parabolic signals. Thus, we are changing the expected profit/loss ratio to the breakeven point. If the price meets the stop loss level (46.60) without reaching the order (43.89), we recommend cancelling the order: the market has undergone internal changes which were not taken into account.
Fundamental Analysis of -
Pfizer stock retreated after president Biden said pandemic is over. Will the Pfizer stock price rebound?
Stocks of pharmaceutical companies dropped on Monday after US President Biden said that the pandemic is over in the United States in an interview over the weekend. Pfizer stock closed 1.2% lower on the day after Biden’s interview. Expectations of lower vaccine demand is bearish for pharmaceutical companies’ stocks. Recently, the Food and Drug Administration granted emergency use authorization (EUA) to Pfizer/BioNTech and Moderna’s Omicron BA.4/BA.5-adapted bivalent vaccines for use as a single booster dose. While the pace of new hospitalizations has slowed down public health officials warn of a possible surge in infections in the fall and winter months.